Akers Biosciences, Inc. has formed an Advisory Board with expertise in the hemp and minor cannabinoid industry to assist the Board of Directors in its strategic review including, potentially, the extraction, testing, purification and formulation of safe cannabinoids within the hemp industry. The Advisory Board may also explore a pathway to consumer products with a focus on minor cannabinoids. The company intends to work closely with its new Advisory Board members Bob Hoban and Michael Patterson, as well as its own legal counsel. Hoban is the President and Founder of Hoban Law Group. Patterson is a Health Care executive with over 25 years of experience who is currently the Chief Executive Officer of U.S. Cannabis Pharmaceutical Research and Development LLC. Michael is a subject matter expert in the Global Cannabis Industry and a Board member of the American Journal of Endocannabinoid Medicine.